Clinical Trials Browser

Withdrawn × Breast Neoplasms × Tamoxifen × Clear all

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT00053339 2016-07-12

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Phase 3 Withdrawn

Breast Neoplasms